According to a new market research report published by Acute Market Reports “macrogol laxatives market By Drug Name (Movicol; Casenlax; VistaPrep; CosmoCol; Molaxole; Endofalk; Glycoprep; Forlax; Laxido; MiraLAX and Other Macrogols), By Disease (Inflammatory Bowel Diseases (IBD); Irritable Bowel Syndrome (IBS); Drug Induced Constipation (DIC); and Other Diseases), By Age Group (Baby Boomers and Older; Generation X; Millennials; Generation Z; and Generation Alpha) - Growth, Future Prospects and Competitive Analysis, 2020 – 2032”, the global electric kick scooters market is expected to witness continued growth during the forecast period from 2020 to 2032.
The complete report is available at https://www.acutemarketreports.com/report/macrogol-laxative-market
Market Insights
The usage of Macrogol as a laxative is primarily driven by the demand through the drug induced constipation segment. Due to the rising need for medication related to several chronic diseases and other complexities, a large number of people have been facing issues related to drug-induced constipation. Thereby, there has been a growing demand for Macrogol-based laxatives. In addition, the usage of Macrogol is highly popular in cases of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). In 2023, the overall Macrogols market worldwide is led by the drug induced constipation segment. On account of high level of constipation occurring due to intake of opioids and other medications, there have been an increasing number of people suffering from drug induced constipation. Macrogol-based laxatives have been proven to be very effective in relieving bowel during constipation in such cases. In addition, Macrogol has been a popular line of treatment in cases of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Thereby, the Macrogol market is expected to grow at a steady rate with a CAGR of 4.6% during the forecast period from 2020 to 2032.
Competitive Insights:
macrogol laxatives market is highly fragmented and characterized by the presence of a large number of regional players. Most of the leading players in the macrogol laxatives market manufacture and market such laxatives within their regional markets and only few companies have collaborated with international distributors for expanding their geographic reach. Some of the key manufactures of Macrogol laxatives include Norgine B.V., RECORDATI S.p.A., Tillotts Pharma AG, Stirling Anglian Pharmaceuticals, Meda AS, Dr. Falk Pharma GmbH, Fresenius Kabi Australia Pty Limited, Ipsen Group, Galen Limited, and Bayer Health Care LLC.
Key Trends:
